Mirador

Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company's Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly develop new precision medicines for patients with chronic immune-mediated inflammatory and fibrotic diseases. Founded in 2024 and headquartered in San Diego, California, Mirador has raised over $400 million from leading life science investors.